Differentiating WFS1 (wolframin mutation), usually presenting with diabetes mellitus and optic atrophy, from WFS2 (CISD2 mutation), often associated with additional gastrointestinal ulceration and bleeding, remains important in guiding counseling and prognosis. Here, CISD2 is linked to hereditary optic atrophy.